Learn more about entyvio® (vedolizumab), a biologic treatment for moderate to severe ulcerative colitis or crohn's disease in adults. Entyvio® dosing and administration for iv infusion and subcutaneous injection Entyvio is indicated in adults for the treatment of
A close up of a young girl wearing a blue headband - SeaArt AI
Moderately to severely active ulcerative colitis (uc)
Moderately to severely active crohn's disease (cd)
The combined storage time of reconstituted entyvio solution in the vial and the diluted solution in the infusion bag with 0.9% sodium chloride injection is a total of 12 hours at room temperature (20° to 25°c [68° to 77°f]) or 24 hours refrigerated (2° to 8°c [36° to 46°f]) This combined storage time may include up to eight hours of the reconstituted solution in the vial at 2° to 8. These highlights do not include all the information needed to use entyvio safely and effectively Entyvio®) is a medication used to treat crohn’s disease and ulcerative colitis
It is an antibody that prevents inflammation causing white blood cells from entering and damaging the intestine It targets the gastrointestinal (gi) tract rather than your whole body’s immune system.
